1. Home
  2. FSBW vs CKPT Comparison

FSBW vs CKPT Comparison

Compare FSBW & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • CKPT
  • Stock Information
  • Founded
  • FSBW 1936
  • CKPT 2014
  • Country
  • FSBW United States
  • CKPT United States
  • Employees
  • FSBW N/A
  • CKPT N/A
  • Industry
  • FSBW Banks
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • CKPT Health Care
  • Exchange
  • FSBW Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • FSBW 299.5M
  • CKPT 335.9M
  • IPO Year
  • FSBW 2012
  • CKPT 2017
  • Fundamental
  • Price
  • FSBW $39.82
  • CKPT $4.17
  • Analyst Decision
  • FSBW Hold
  • CKPT Buy
  • Analyst Count
  • FSBW 1
  • CKPT 3
  • Target Price
  • FSBW $44.00
  • CKPT $4.33
  • AVG Volume (30 Days)
  • FSBW 16.5K
  • CKPT 1.0M
  • Earning Date
  • FSBW 04-22-2025
  • CKPT 05-16-2025
  • Dividend Yield
  • FSBW 2.81%
  • CKPT N/A
  • EPS Growth
  • FSBW N/A
  • CKPT N/A
  • EPS
  • FSBW 4.36
  • CKPT N/A
  • Revenue
  • FSBW $139,150,000.00
  • CKPT $41,000.00
  • Revenue This Year
  • FSBW $8.34
  • CKPT $102,182.93
  • Revenue Next Year
  • FSBW $5.99
  • CKPT $351.71
  • P/E Ratio
  • FSBW $9.20
  • CKPT N/A
  • Revenue Growth
  • FSBW 0.09
  • CKPT N/A
  • 52 Week Low
  • FSBW $31.46
  • CKPT $1.47
  • 52 Week High
  • FSBW $49.15
  • CKPT $4.50
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 57.41
  • CKPT 71.99
  • Support Level
  • FSBW $38.00
  • CKPT $4.02
  • Resistance Level
  • FSBW $40.34
  • CKPT $4.17
  • Average True Range (ATR)
  • FSBW 0.93
  • CKPT 0.03
  • MACD
  • FSBW 0.10
  • CKPT -0.01
  • Stochastic Oscillator
  • FSBW 71.94
  • CKPT 93.33

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Share on Social Networks: